Gene therapy for haemophilia A and B was discussed during several sessions at the 64th American Society of Hematology (ASH) Annual Meeting, held 10th–13th December 2022.

What are the generation differences in how HCPs want to talk to pharma? Three generations of doctors share their thoughts.

Ovarian cancer is the seventh most commonly diagnosed cancer among females and the most lethal gynaecologic malignancy globally because of its vague presentation, insidious nature, recurrence, and drug resistance.

AstraZeneca’s Mina Makar talks about solving unmet needs and how to champion the patient perspective.

Many top pharma companies have cut their Twitter ad spend after the Eli Lilly scandal, but should they take a risk and return?

Roche’s Davidek Herron offers five top tips for pharma teams striving for omnichannel excellence.

How can pharma maximise the impact of key opinion leaders in the ever-evolving digital world?